(Q39555982)

13 September 2017

title

Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice (English)

1 reference

13 September 2017

John Maher

11

0 references

author name string

Ana Caterina Parente-Pereira

1

1 reference

13 September 2017

Jerome Burnet

2

1 reference

13 September 2017

David Ellison

3

1 reference

13 September 2017

Julie Foster

4

1 reference

13 September 2017

David Marc Davies

5

1 reference

13 September 2017

Sjoukje van der Stegen

6

1 reference

13 September 2017

Sophie Burbridge

7

1 reference

13 September 2017

Laura Chiapero-Stanke

8

1 reference

13 September 2017

Scott Wilkie

9

1 reference

13 September 2017

Stephen Mather

10

1 reference

13 September 2017

publication date

20 April 2011

1 reference

Journal of Clinical Immunology

13 September 2017

published in

1 reference

13 September 2017

volume

31

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

710-718

1 reference

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

T cell receptor gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

T-cell engineering for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Tumor-driven evolution of immunosuppressive networks during malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Structural analysis of an epidermal growth factor/transforming growth factor-alpha chimera with unique ErbB binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Stabilized imaging of immune surveillance in the mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Activation induces rapid and profound alterations in the trafficking of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

The liver as a site of T-cell apoptosis: graveyard, or killing field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer: efficacy, toxicity, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9532-8

In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis

21 January 2018

1 reference

12 December 2020

Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations

1 reference

12 December 2020

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

1 reference

12 December 2020

c-erbB growth-factor-receptor proteins in ovarian tumours

1 reference

12 December 2020

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

1 reference

12 December 2020

The recirculating lymphocyte pool of the rat: a systematic description of the migratory behaviour of recirculating lymphocytes

1 reference

12 December 2020

Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2

1 reference

12 December 2020

Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer

1 reference

12 December 2020

Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice.

1 reference

12 December 2020

10.1007/S10875-011-9532-8

Identifiers

DOI

1 reference

13 September 2017

1 reference